Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

Oliver, J, Nair, N, Orozco, G et al. (8 more authors) (2021) Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment. Arthritis Research & Therapy, 23 (1). 80. ISSN 1478-6354

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s). 2021. This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)

Keywords: TNF-inhibitor; Adalimumab; Biomarkers; Gene expression; Longitudinal studies; Rheumatoid arthritis
Dates:
  • Published: December 2021
  • Published (online): 10 March 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
Funder
Grant number
NIHR National Inst Health Research
BRC
MRC (Medical Research Council)
R116825
Depositing User: Symplectic Publications
Date Deposited: 26 May 2021 10:05
Last Modified: 26 May 2021 10:05
Status: Published
Publisher: BMC
Identification Number: 10.1186/s13075-021-02451-9
Open Archives Initiative ID (OAI ID):

Commentary/Response Threads

Export

Statistics